Protocol No. | UW24143 IVY-P3-24-021 |
||
---|---|---|---|
Principal Investigator | Bhatia, Ankush | ||
Phase | III | ||
Age Group | Adult | ||
ClinicalTrials.Gov | NCT06388733 (Click to jump to clinicaltrials.gov) | ||
Management Group(s) | Brain/Central Nervous System | ||
Title
Description
Objective
Treatment
Participants will be randomly assigned to one of two treatment arms: niraparib or TMZ.
Key Eligibility
Inclusion Criteria:
Applicable Disease Sites
Participating Institutions
|